North America Onychomycosis Treatment 麻豆原创 2021-2031 by Onychomycosis Type , Treatment Type , Distribution Channel , and Country: Trend Forecast and Growth Opportunity

Publication ID:

GRM0422026

Publication Date:

April 30, 2022

Pages:

Publisher:

Grace 麻豆原创 Data

Countries:

North America [1]

USD 2,800.00

Treatments [2]

Diseases [3]

Pharma & Healthcare [4]

Description:

North America onychomycosis treatment market is projected to grow by 7.2% annually in the forecast period and reach $2,111.2 million by 2031, driven by the increasing prevalence of chronic medical ailments, the growing geriatric population, improved therapies and preventative solutions, and the rising healthcare expenditure.
Highlighted with 21 tables and 36 figures, this 87-page report 鈥淣orth America Onychomycosis Treatment 麻豆原创 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire North America onychomycosis treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America onychomycosis treatment market in every aspect of the classification from perspectives of Onychomycosis Type, Treatment Type, Distribution Channel, and Country.

Based on Onychomycosis Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Distal Subungual Onychomycosis
鈥� White Superficial Onychomycosis
鈥� Proximal Subungual Onychomycosis
鈥� Candidal Onychomycosis
鈥� Other Onychomycosis Types

Based on Treatment Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Drug Treatment
鈥� Laser Therapy
鈥� Photodynamic Therapy
鈥� Other Therapies

By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Hospitals and Clinics
鈥� Online Stores
鈥� Retail Pharmacies
鈥� Other Distribution Channels

Geographically, the following national/local markets are fully investigated:
鈥� U.S.
鈥� Canada
鈥� Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Onychomycosis Type, Treatment Type and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Bausch Health Companies Inc.
Bayer AG
Cipla Ltd
Dr. Reddys Laboratories Ltd
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
Lumenis Ltd
Medimetriks Pharmaceuticals Inc.
Moberg Pharma AB
Novartis AG
Pfizer Inc.
Sanofi SA
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of 麻豆原创 Research Methodology 10
1.2.2 麻豆原创 Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 麻豆原创 Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 麻豆原创 Overview and Dynamics 17
2.1 麻豆原创 Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 18
2.1.2 Impact of COVID-19 on the 麻豆原创 20
2.2 Major Growth Drivers 22
2.3 麻豆原创 Restraints and Challenges 29
2.4 Emerging Opportunities and 麻豆原创 Trends 32
2.5 Porter鈥檚 Fiver Forces Analysis 36
3 Segmentation of North America 麻豆原创 by Onychomycosis Type 40
3.1 麻豆原创 Overview by Onychomycosis Type 40
3.2 Distal Subungual Onychomycosis 42
3.3 White Superficial Onychomycosis 43
3.4 Proximal Subungual Onychomycosis 44
3.5 Candidal Onychomycosis 45
3.6 Other Onychomycosis Types 46
4 Segmentation of North America 麻豆原创 by Treatment Type 47
4.1 麻豆原创 Overview by Treatment Type 47
4.2 Drug Treatment 49
4.3 Laser Therapy 50
4.4 Photodynamic Therapy 51
4.5 Other Therapies 52
5 Segmentation of North America 麻豆原创 by Distribution Channel 53
5.1 麻豆原创 Overview by Distribution Channel 53
5.2 Hospitals and Clinics 55
5.3 Online Stores 56
5.4 Retail Pharmacies 57
5.5 Other Distribution Channels 58
6 North America 麻豆原创 2021-2031 by Country 59
6.1 Overview of North America 麻豆原创 59
6.2 U.S. 62
6.3 Canada 65
6.4 Mexico 67
7 Competitive Landscape 69
7.1 Overview of Key Vendors 69
7.2 New Product Launch, Partnership, Investment, and M&A 72
7.3 Company Profiles 73
Bausch Health Companies Inc. 73
Bayer AG 75
Cipla Ltd 76
Dr. Reddys Laboratories Ltd 77
Galderma SA 78
GlaxoSmithKline PLC 79
Johnson & Johnson 80
Lumenis Ltd 81
Medimetriks Pharmaceuticals Inc. 82
Moberg Pharma AB 83
Novartis AG 84
Pfizer Inc. 85
Sanofi SA 86
RELATED REPORTS 87

Companies Mentioned:

Selected Key Players:
Bausch Health Companies Inc.
Bayer AG
Cipla Ltd
Dr. Reddys Laboratories Ltd
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
Lumenis Ltd
Medimetriks Pharmaceuticals Inc.
Moberg Pharma AB
Novartis AG
Pfizer Inc.
Sanofi SA
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.